Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation

Author:  ["Irene H Cheng","Jorge J Palop","Luke A Esposito","Nga Bien-Ly","Fengrong Yan","Lennart Mucke"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

The Arctic mutation within the amyloid-β (Aβ) peptide causes Alzheimer disease. In vitro, Arctic-mutant Aβ forms (proto)fibrils more effectively than wild-type Aβ. We generated transgenic mouse lines expressing Arctic-mutant human amyloid precursor proteins (hAPP). Amyloid plaques formed faster and were more extensive in Arctic mice than in hAPP mice expressing wild-type Aβ, even though Arctic mice had lower Aβ1-42/1-40 ratios. Thus, the Arctic mutation is highly amyloidogenic in vivo.

Cite this article

Cheng, I., Palop, J., Esposito, L. et al. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 10, 1190–1192 (2004). https://doi.org/10.1038/nm1123

View full text

>> Full Text:   Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation

Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C

Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resist